Search filters

List of works by Vivek Roy

A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin

scientific article published on 31 December 2012

Activity of pomalidomide in patients with immunoglobulin light-chain amyloidosis

scientific article

Autologous stem cell transplantation and IgM amyloidosis

scientific article published on June 2006

Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma

scientific article

Conflicts of interest, authorship, and disclosures in industry-related scientific publications

scientific article

Diagnosis and Management of Waldenström Macroglobulinemia: Mayo Stratification of Macroglobulinemia and Risk-Adapted Therapy (mSMART) Guidelines 2016.

scientific article published on 05 January 2017

Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines

scientific article

Immunoglobulin D amyloidosis: a distinct entity

scientific article published on 07 November 2011

Impact of pretransplant therapy and depth of disease response before autologous transplantation for multiple myeloma

scientific article

Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone

scientific article published on 26 March 2009

Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

scientific article

Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial

scientific article

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines

scientific article published on December 2009

Management of newly diagnosed symptomatic multiple myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus guidelines 2013.

scientific article published on April 2013

Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma

scientific article published on August 2006

Older patients with myeloma derive similar benefit from autologous transplantation.

scientific article

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study

scientific article

Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature

scientific article published on 27 July 2004

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma

scientific article

Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease

scientific article published on 20 June 2011

Pomalidomide, Bortezomib and Dexamethasone (PVD) for Patients with Relapsed, Lenalidomide Refractory Multiple Myeloma

scientific article

Primary Cutaneous T-Cell Lymphoblastic Lymphoma: Case Report and Literature Review

article

Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

scientific article published on 4 October 2016

Salvage second hematopoietic cell transplantation in myeloma

scientific article

Smoldering multiple myeloma requiring treatment: time for a new definition?

scientific article

Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy

scientific article published on 10 March 2017

Treatment of Immunoglobulin Light Chain Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement

scientific article published on August 2015

Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement

scientific article published on March 2007

Use of KRD-PACE as Salvage Therapy in Aggressive, Relapsed/Bortezomib-Refractory Extramedullary Multiple Myeloma: A Report of Two Cases and Literature Review

scientific article published on 18 February 2020

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement.

scientific article

Paulina is supported by:

About Paulina

Help